CCND1 and endometrial cancer: The rate of overall CCND1 mutations in endometrial cancer in our study is higher than that reported by Ikeda et al and Moreno-Bueno et al, likely reflecting the fact that the two prior studies sequenced a target region of cyclin D1 as opposed to next generation sequencing of the whole CCND1 gene.